Trump takes a first step toward returning medical supply chains to the U.S.

Trump administration said it has awarded a $354 million contract to a Virginia start-up that will manufacture a variety of generic drugs and their ingredients — including medicines used to treat covid-19 — at advanced manufacturing facilities in the United States.